Evidence map›Paper›PMID 42050516›Full record

ArticleRespiratory research2026

Respiratory-physiology modeling of therapeutic hydrogen inhalation: defining the fraction of inspired hydrogen (FiH

Tyler W LeBaron, Kinji Ohno, Cordélia Salomez-Ihl, Philippe Cinquin, François Boucher, Motoaki Sano, John N Kheir

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tyler W LeBaronDepartment of Kinesiology and Outdoor Recreation, Southern Utah University, Cedar City, UT, 84720, USA. TylerLeBaron@suu.edu.ORCID http://orcid.org/0000-0001-9164-6728
Kinji OhnoDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.ORCID http://orcid.org/0000-0002-1529-2750
Cordélia Salomez-IhlUniv. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.ORCID http://orcid.org/0000-0003-0756-7221
Philippe CinquinUniv. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.ORCID http://orcid.org/0000-0002-2700-1447
François BoucherUniv. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.ORCID http://orcid.org/0000-0001-6897-9321
Motoaki SanoDepartment of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, 755-8505, Japan.ORCID http://orcid.org/0000-0003-1771-8310
John N KheirDepartment of Cardiology, Division of Cardiovascular Critical Care, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-6080-8739

Funding

National Institute of Child Health and Human Development 1R43HD116647-01NHLBI NIH HHS 4R33HL164373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dose–responseFlammabilityFraction of inspired hydrogen (FiH2)Hydrogen flow rateHydrogen inhalationMolecular hydrogen (H2)Nasal cannulaOptimal H2 concentrationOxyhydrogenTherapeutic dosing

Identifiers

PMID42050516
PMCPMC13312717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.